Abstract |
We have previously shown that p38 mitogen-activated protein kinase (MAPK) inhibitors, which block the production and action of inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), are effective in models of bone and cartilage degradation. To further investigate the role of p38 MAPK, we have studied its activation in osteoblasts and chondrocytes, following treatment with a panel of proinflammatory and osteotropic agents. In osteoblasts, significant activation of p38 MAPK was observed following treatment with IL-1 and TNF, but not parathyroid hormone, transforming growth factor-beta ( TGF-beta), 1,25(OH)(2)D(3), insulin-like growth factor-1 (IGF-1), or IGF-II. Similar results were obtained using primary bovine chondrocytes and an SV40-immortalized human chondrocyte cell line, T/C28A4. SB 203580, a selective inhibitor of p38 MAPK, inhibited IL-1 and TNF-induced p38 MAPK activity and IL-6 production (IC(50)s 0.3--0.5 microM) in osteoblasts and chondrocytes. In addition, IL-1 and TNF also activated p38 MAPK in fetal rat long bones and p38 MAPK inhibitors inhibited IL-1- and TNF-stimulated bone resorption in vitro in a dose-dependent manner (IC(50)s 0.3--1 microM). These data support the contention that p38 MAPK plays a central role in regulating the production of, and responsiveness to, proinflammatory cytokines in bone and cartilage. Furthermore, the strong correlation between inhibition of kinase activity and IL-1 and TNF-stimulated biological responses indicates that selective inhibition of the p38 MAPK pathway may have therapeutic utility in joint diseases such as rheumatoid arthritis (RA).
|
Authors | S Kumar, B J Votta, D J Rieman, A M Badger, M Gowen, J C Lee |
Journal | Journal of cellular physiology
(J Cell Physiol)
Vol. 187
Issue 3
Pg. 294-303
(Jun 2001)
ISSN: 0021-9541 [Print] United States |
PMID | 11319753
(Publication Type: Journal Article)
|
Copyright | Copyright 2001 Wiley-Liss, Inc. |
Chemical References |
- Calcium Radioisotopes
- Cytokines
- Enzyme Inhibitors
- Growth Substances
- Interleukin-1
- Interleukin-6
- Tumor Necrosis Factor-alpha
- Mitogen-Activated Protein Kinases
- p38 Mitogen-Activated Protein Kinases
|
Topics |
- Animals
- Biological Assay
- Bone Resorption
(enzymology)
- Calcium Radioisotopes
(analysis, metabolism)
- Cattle
- Cells, Cultured
- Chondrocytes
(cytology, drug effects, enzymology)
- Culture Techniques
- Cytokines
(pharmacology)
- Dose-Response Relationship, Drug
- Enzyme Activation
(drug effects, physiology)
- Enzyme Inhibitors
(pharmacology)
- Growth Substances
(pharmacology)
- Humans
- Interleukin-1
(metabolism, pharmacology)
- Interleukin-6
(biosynthesis)
- Mitogen-Activated Protein Kinases
(antagonists & inhibitors, metabolism)
- Osteoblasts
(cytology, drug effects, enzymology)
- Radius
(cytology, embryology, enzymology)
- Rats
- Rats, Sprague-Dawley
- Signal Transduction
(drug effects, physiology)
- Tumor Necrosis Factor-alpha
(metabolism, pharmacology)
- Ulna
(cytology, embryology, enzymology)
- p38 Mitogen-Activated Protein Kinases
|